Markers of endothelial dysfunction and insulin resistance. beneficial effects of rosiglitazone in type 2 diabetes

被引：0
|
作者：
Albertini, JP
Chen, HZ
Mather, R
Valensi, P
机构：
来源：
DIABETES | 2004年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A117 / A117
页数：1
相关论文
共 50 条
  • [21] Rosiglitazone improves endothelial function in patients with type 2 diabetes treated with insulin
    Naka, Katerina K.
    Papathanassiou, Katerina
    Bechlioulis, Aris
    Pappas, Konstantinos
    Kazakos, Nikolaos
    Kanioglou, Chryssanthi
    Papafaklis, Michail I.
    Kostoula, Aggeliki
    Vezyraki, Patra
    Makriyiannis, Demetrios
    Tsatsoulis, Agathocles
    Michalis, Lampros K.
    DIABETES & VASCULAR DISEASE RESEARCH, 2011, 8 (03): : 195 - 201
  • [22] Role of resistin sequence variation in type 2 diabetes and insulin resistance.
    Wang, H
    Chu, W
    Hemphill, C
    Elbein, SC
    AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) : 505 - 505
  • [23] Differential effects of rosiglitazone and insulin glargine on inflammatory markers, glycemic control, and lipids in type 2 diabetes
    Reynolds, L. Raymond
    Kingsley, Felicia J.
    Karounos, Dennis G.
    Tannock, Lisa R.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 77 (02) : 180 - 187
  • [24] Oxidative DNA damage in Type 2 diabetes is associated with insulin resistance.
    Suzuki, S
    Hinokio, Y
    Hirai, M
    Chiba, M
    Komatsu, K
    Takahashi, K
    Ishihara, T
    Katagiri, H
    Satoh, J
    Toyota, T
    Oka, Y
    DIABETOLOGIA, 2002, 45 : A173 - A173
  • [25] Markers of endothelial dysfunction predict incident type 2 diabetes
    Meigs, JB
    Wilson, PWF
    Tofler, GH
    Fox, CS
    Nathan, DM
    D'Agostino, RB
    O'Donnell, CJ
    DIABETES, 2005, 54 : A90 - A90
  • [26] Endothelial dysfunction precedes the development of hypertension in diet induced insulin resistance.
    Katakarn, PVG
    Uihelyi, MR
    Winecoff, AP
    FASEB JOURNAL, 1998, 12 (04): : A190 - A190
  • [27] Insulin resistance and endothelial dysfunction studied in type-2 diabetes mellitus with and without microalbuminuria
    Yu, YR
    Suo, LX
    Yu, HL
    DIABETES, 2003, 52 : A516 - A516
  • [28] Rosiglitazone improves postprandial glycaemia and markers of endothelial function in patients with Type 2 diabetes
    Agrawal, A
    Chen, H
    Yan, Y
    Mather, R
    Albertini, JP
    Valensi, P
    Hanefeld, M
    DIABETOLOGIA, 2002, 45 : A251 - A251
  • [29] Rosiglitazone improves postprandial glycemia and markers of endothelial function in patients with type 2 diabetes
    Agrawal, A
    Chen, HZ
    Yan, Y
    Mather, R
    Albertini, JP
    Valensi, P
    Hanefeld, M
    DIABETES, 2002, 51 : A92 - A92
  • [30] The insulin sensitizer rosiglitazone improves endothelial function in insulin-dependent patients with type 2 diabetes
    Naka, K.
    Papathanassiou, K.
    Kazakos, N.
    Bechlioulis, A.
    Pappas, K.
    Liveris, K.
    Makriyiannis, D.
    Tsatsoulis, A.
    Michalis, L. K.
    EUROPEAN HEART JOURNAL, 2007, 28 : 466 - 466
12345